1.4 Medical & Pregnancy History

On the ABGC CGC exam, Domain 1A Clinical Information items test whether you can turn a messy referral into a usable clinical picture. Medical history and pregnancy history are not intake paperwork; they are the primary data that decide whether a presentation looks Mendelian, chromosomal, multifactorial, teratogenic, or infectious—and how urgently the client needs counseling or testing.

Why history is a scored clinical skill

Genetic counselors rarely start with a completed genotype. You start with a phenotype narrative: a fetus with a heart defect, a child with hypotonia, a pregnant person exposed to a medication, or a couple with recurrent pregnancy loss. The CGC expects you to know what to ask, how to organize answers, and how those answers change the differential and the next action.

History-taking in genetic counseling has three concurrent goals:

1. Characterize the phenotype — onset, severity, organ systems, developmental course, imaging/lab findings.
2. Identify non-genetic and pregnancy-related modifiers — medications, infections, maternal disease, substance use, radiation, workplace exposures.
3. Frame reproductive context — timing in gestation, prior losses or anomalies, fertility treatments, and whether decisions are time-sensitive.

Pedigree construction (Domain 2) sits beside this work, but Domain 1A focuses on the index client's medical and obstetric story as clinical information in its own right.

Personal medical history: what matters for genetics

A useful personal history is system-oriented and genetics-aware. You are hunting for findings that either suggest a hereditary condition or mimic one.

Ask about prior genetic testing (karyotype, microarray, panels, exome, NIPT, carrier screening) and obtain reports when possible. A "negative" test is only informative if you know the method and indication.

Scenario: incomplete medical history

A pediatrician refers a 3-year-old with "possible genetic syndrome" for global delay and a ventricular septal defect. If you only note "delay + VSD," you may jump to microarray. If history also reveals maternal uncontrolled diabetes with HbA1c 11% in the first trimester and caudal regression spectrum findings, the non-genetic contribution rises sharply—even though a chromosomal cause is still possible and often still worth excluding. CGC items reward counselors who integrate medical history rather than treating every anomaly as purely Mendelian.

Pregnancy history: structure that exam writers expect

Use a reproducible obstetric framework so you do not miss exposure timing.

Core obstetric elements

• Gravidity and parity (GP or GTPAL as used locally), including ectopic pregnancies and terminations.
• Dating: last menstrual period (LMP), estimated due date, and how dating was confirmed (ultrasound crown–rump length vs uncertain dates).
• Current gestation: gestational age (GA) today; trimester; planned vs unplanned; fertility treatment (IVF, ICSI, donor gametes, PGT).
• Prenatal care course: ultrasounds (nuchal translucency, anatomy survey, growth), serum screening, NIPT results, diagnostic procedures offered or done.
• Pregnancy complications: bleeding, hypertension, gestational diabetes, oligohydramnios/polyhydramnios, IUGR, preterm labor.
• Fetal phenotype: each anomaly with GA at detection and whether findings are isolated or multiple.

Prior pregnancy outcomes

Document each prior pregnancy separately:

• Live births: sex, gestational age, birth weight, congenital anomalies, neonatal death, developmental outcome.
• Losses: miscarriage (GA), stillbirth, termination for anomaly (what was known), molar pregnancy.
• Pattern recognition: recurrent early loss may raise chromosomal rearrangement questions; recurrent mid-trimester loss with cervical insufficiency is a different differential; recurrent anomalies in the same organ system raise Mendelian or teratogenic recurrence concerns.

Exposure and illness timeline

For every medication, infection, toxin, or illness, record:

1. What (drug name/dose, pathogen, radiation type/dose if known).
2. When relative to LMP or conception (days/weeks GA).
3. Duration and intensity (single dose vs chronic; fever height; viral load if known).
4. Confirmation (lab-proven infection vs clinical suspicion; prescription fill vs patient recall).

Organogenesis is heavily front-loaded. Many classic teratogens are most dangerous in the embryonic period (roughly weeks 3–8 post-conception), with some exceptions (for example, alcohol and some infections can harm later). Vague history such as "took antibiotics early" without drug identity and week is not actionable.

Maternal disease as pregnancy history

Maternal medical conditions are part of pregnancy history because they alter fetal risk independently of Mendelian inheritance:

• Pregestational diabetes — caudal regression, neural tube defects, cardiac defects; risk correlates with early glycemic control.
• Maternal PKU — microcephaly, intellectual disability, congenital heart defects when phenylalanine is poorly controlled peri-conception.
• Autoimmune disease and anticoagulation — medication choices (for example warfarin vs heparin) matter more than the diagnosis label alone.
• Seizure disorders — distinguish epilepsy itself from anticonvulsant teratogenicity; valproate is a high-yield example.
• Infectious disease history — TORCH-type risks, Zika travel, CMV serostatus context.

How counselors use history in real time

Elicitation technique matters:

• Start with open questions ("Walk me through this pregnancy from the beginning"), then narrow.
• Use teach-back for medication names; show pill bottles or pharmacy lists when possible.
• Separate patient-reported vs chart-documented findings; reconcile conflicts.
• Note psychosocial barriers (trauma, stigma around substance use, immigration-related care gaps) that may suppress disclosure—without abandoning the clinical need for accurate exposure data.
• Translate history into a problem list: primary indication, secondary findings, exposures, maternal disease, prior outcomes, open genetic testing questions.

Exam traps

• Treating family history as a substitute for the index client's medical/pregnancy history.
• Ignoring gestational timing when an exposure is mentioned.
• Assuming every congenital anomaly equals a genetic syndrome indication without considering maternal diabetes, infection, or teratogen.
• Failing to ask about ART/donor gametes when interpreting "family history" risk.
• Over-relying on a single NIPT result without integrating anatomy findings and personal history.
• Documenting "noncontributory" when the history was simply not taken.

Putting it together: a prenatal referral

Indication: "abnormal anatomy scan—possible genetic." Effective history might reveal: G3P1, prior child with bilateral cleft lip, current pregnancy with isolated cleft at 20 weeks, no teratogen exposures, negative aneuploidy screen, maternal uncle with cleft—shifting weight toward multifactorial recurrence plus possible syndromic evaluation, not an immediate assumption of trisomy. Another version of the same scan indication might reveal first-trimester isotretinoin exposure with cranial neural crest pattern anomalies—shifting urgency toward teratogen counseling and targeted evaluation rather than a broad hereditary cancer-style panel.

History is the scaffold for Sections 1.5 and 1.6: once exposures and phenotypes are timed and characterized, you can classify non-genetic risks and triage differential diagnosis and referral urgency.